NSE: ZYDUSWELL | BSE: 531335

Mid-range Performer

Download real time

2018.70 -12.30 (-0.61%)

35.19% Gain from 52W Low

30,596 NSE+BSE Volume

NSE 29 Aug, 2025 3:31 PM (IST)

12,845.4

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Split

Zydus Wellness Ltd. has split the face value of its shares from ₹10 to ₹2 on 18 Sep 2025. See details

Zydus Wellness Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ZYDUSWELL, BSE:531335 Zydus Wellness Ltd.

Search Inside the pdf :

Zydus Wellness Ltd.

05 Aug 2025

2018.70

-0.61%

ZWL’s Q1FY26 numbers were soft, with muted revenue growth and lower margins that dragged down PAT. Consolidated revenue grew by 2.4% y-o-y to Rs. 861 crore, in line with our expectation of Rs. 858 crore.

Mutual Funds have increased holdings from 11.61% to 18.39% in Jun 2025 qtr.

Zydus Wellness Ltd.

05 Aug 2025

2018.70

-0.61%

Soft Q4

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Ltd. is trading above all available SMAs

Zydus Wellness Ltd.

21 May 2025

2018.70

-0.61%

BP Equities Q4FY25 Result Update Zydus Wellness Ltd

Results Update: Zydus Wellness Ltd.

BP Wealth

Mutual Funds have increased holdings from 11.61% to 18.39% in Jun 2025 qtr.

Zydus Wellness Ltd.

13 Feb 2025

2018.70

-0.61%

Mixed bag Q3

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Limited’s (ZWL’s) Q3FY25 numbers were mixed with revenue beating estimates and growing by 14.6% y-o-y to Rs. 462 crore (versus expectation of Rs. 435 crore), while OPM stood flat y-o-y at 3.1% and missed expectations of 5.8%. Volume growth stood at 4.8%.

Zydus Wellness Ltd. has an average target of 2145.50 from 3 brokers.

Zydus Wellness Ltd.

05 Feb 2025

2018.70

-0.61%

Zydus Wellness (HOLD): Margin focus over reinvestments

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

Q3FY25 sales came in 2% above consensus while EBITDA was 2% lower due to 15bps lower-than-expected margins

Zydus Wellness Ltd. has an average target of 2145.50 from 3 brokers.

Zydus Wellness Ltd.

11 Nov 2024

2018.70

-0.61%

Mixed bag Q2

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Limited’s (ZWL’s) Q2FY2025 numbers were mixed with revenue growing by 12% y-o-y to Rs. 493 crore (versus Rs. 475 crore expected), while OPM stood flat y-o-y at 4% (against expectation of 5.3%). Adjusted PAT came in at Rs. 16 crore.

Mutual Funds have increased holdings from 11.61% to 18.39% in Jun 2025 qtr.

Zydus Wellness Ltd.

27 Aug 2024

2018.70

-0.61%

Focused strategies to drive double-digit growth

Buy: Zydus Wellness Ltd.

Target

Sharekhan

We maintain a Buy on Zydus Wellness Limited (ZWL) with an unchanged PT of Rs. 3,000. Stock has run up by 32% since our upgrade to Buy on May 14, 2024.

Zydus Wellness Ltd. is trading above all available SMAs

Zydus Wellness Ltd.

03 Aug 2024

2018.70

-0.61%

Zydus Wellness (HOLD): 1QFY25 result review: Risk from La Nina

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

Sales (+20%) were 7% higher on heatwave but EBITDA was in line with Bloomberg consensus. We forecast +13% sales growth in FY25

Number of FII/FPI investors increased from 126 to 135 in Jun 2025 qtr.

Zydus Wellness Ltd.

13 Feb 2024

2018.70

-0.61%

First Light | Amber Enterprises, CPI And IIP, Credit Composition, Hero Motocorp, Thermax, Bandhan Bank, Indraprastha Gas, Zydus Wellness

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

AMBER: Persistent near-term challenges; cut to SELL. CPI and IIP: Still some pain points on inflation. Credit Composition: Study on personal loans. HMCL: Healthy quarter but positives priced in. TMX: Improving order outlook; maintain HOLD. BANDHAN: Recovery on track. IGL: Legacy UP, new GAs can offset slowdown, reiterate BUY. ZYWL: Seasonally weak quarter